AffiAB® Goat anti-NSP9 (SARS-CoV-2) Polyclonal IgG Antibody

The AffiAB® Goat anti-NSP9 (SARS-CoV-2) Polyclonal IgG Antibody is an antibody designed to specifically target and detect the NSP9 protein of the SARS-CoV-2 virus. NSP9, also known as non-structural protein 9, is one of the essential non-structural proteins encoded by the viral RNA of SARS-CoV-2.

This polyclonal antibody is generated by immunizing goats with purified NSP9 protein or a specific peptide sequence derived from NSP9. Following immunization, the antibody is purified from goat serum using various techniques to ensure high specificity and quality.

The AffiAB® Goat anti-NSP9 (SARS-CoV-2) Polyclonal IgG Antibody is widely used in research and diagnostic applications to study the SARS-CoV-2 virus. It can be employed in techniques such as Western blotting, immunohistochemistry, immunofluorescence, and ELISA to detect and analyze the expression and localization of NSP9 in infected cells or patient samples.

By specifically targeting NSP9, this antibody enables researchers to investigate the function and role of this protein in the viral replication cycle and the pathogenesis of SARS-CoV-2. NSP9 is known to be involved in RNA replication and is crucial for viral genome replication and transcription.

Understanding NSP9 and its interactions with other viral and host factors is important for unraveling the molecular mechanisms of SARS-CoV-2 replication and identifying potential therapeutic targets. The AffiAB® Goat anti-NSP9 (SARS-CoV-2) Polyclonal IgG Antibody serves as a valuable tool for researchers studying the SARS-CoV-2 virus, contributing to advancements in virology, immunology, and COVID-19 research.